InvestorsHub Logo
Followers 119
Posts 9122
Boards Moderated 0
Alias Born 07/17/2005

Re: None

Monday, 10/03/2016 8:51:39 AM

Monday, October 03, 2016 8:51:39 AM

Post# of 2149
Wow! "VIVUS will receive an upfront license fee of $70 million. Metuchen will also reimburse VIVUS for payments made to cover royalty and milestone obligations to Mitsubishi Tanabe Pharmaceutical Corporation, or MTPC, during the term of the License Agreement."

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.